Amavita Research Services — Our U.S. Clinical Research Site

bioaccess® and Amavita Research Services LLC are sister organizations under common ownership and leadership. While bioaccess® delivers U.S.-anchored regulatory strategy and Latin American trial execution, Amavita Research Services operates a dedicated clinical research site in Miami, Florida, conducting Phase 1 and early device studies. Together they give sponsors both a U.S.-based, owner-operated research site and a 19-country Latin American execution network.

What this means for sponsors

• A single point of accountability spanning U.S. site-based studies and Latin American first-in-human and early-feasibility execution.
• Shared leadership and quality standards — harmonized SOPs and a single GCP framework (ISO 14155 for devices, ICH E6 for drugs) across both organizations.
• Faster handoffs between U.S. and Latin American phases of a program — no fresh sponsor-site search, no re-contracting from scratch.

Leadership

Julio G. Martinez-Clark serves as Chief Executive Officer of bioaccess® and CEO of Amavita Research Services LLC.

Visit Amavita Research · Contact bioaccess®